l carnitine health L-Carnitine | Metabolic Supplement l-carnitine: Nutrition, pathology, and health

Garcia JM, Polvino WJ

This convenient, shelf-stable glutathione supplement boasts 2.5x better bioavailability than the leading competitor.* It works better, faster, and goes deeper to help maintain a healthy immune system, soothe the digestive tract, and help the mind to think clearly.* Provail ingredient is an all-new glutathione delivery system that is revolutionizing the supplement industry: an ultra-small whey protein matrix, Provail ingredient is a coated glutathione that helps protect it from the harsh conditions of the gastrointestinal tract.* Only when Provail ingredient arrives in the small intestine does it release the Provail glutathione for maximum absorption and peak impact.* Studies showed that Provail ingredient was absorbed 2.5x better, raised blood and tissue levels of glutathione, and boosted blood antioxidant activity more than the leading glutathione brand.* Provail ingredient technology is available exclusively from DaVinci

What the Research Does NOT Yet Support - There are currently no published randomised controlled trials (RCTs) in humans for BPC-157 - Human pharmacokinetic data (how it is absorbed, distributed, metabolised, and excreted) is limited - Optimal dosing, route of administration, and treatment duration have not been established clinically - Long-term safety data in humans is absent - Regulatory approval from the TGA, FDA, or EMA has not been granted for any therapeutic indication TB-500: Evidence Overview What the Research Supports TB-500 / Thymosin Beta-4 has somewhat more human-facing research, though still predominantly preclinical: Phase I and II clinical trials have investigated Thymosin Beta-4 (the native peptide) in cardiac repair following myocardial infarction, with promising safety profiles Wound healing applications have been explored in clinical settings, particularly for chronic non-healing wounds and dry eye disease Robust animal evidence supports its role in reducing inflammation, supporting angiogenesis, and promoting tissue regeneration The native peptide (T4) has demonstrated cardioprotective effects in animal models of heart failure and ischaemia What the Research Does NOT Yet Support TB-500 is a synthetic fragment of T4 it is not identical to the native peptide, and extrapolating human clinical data from T4 studies directly to TB-500 may not be valid No approved therapeutic indications exist for TB-500 specifically Comparative efficacy versus established treatments has not been studied The long-term effects of exogenous peptide administration on endogenous thymosin beta-4 regulation are unknown Potential Benefits: A Summary Based on the available (predominantly preclinical) literature, the following potential benefits have been identified: Risks & Safety Considerations Known & Reported Side Effects Because large-scale human trials are lacking, our understanding of the side effect profile is limited

Protein levels were plotted over the 16 years preceding MASLD diagnosis

Saleh, D